Abaxis Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements, and is a leading global provider of veterinary point-of-care diagnostic products. We provide leading edge technology, tools and services that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices.
Company profile
Ticker
ABAX
Exchange
Website
CEO
Clinton H. Severson
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
770213001
Latest filings (excl ownership)
15-12G
Securities registration termination
10 Aug 18
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 18
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 18
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 18
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 18
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 18
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 18
25-NSE
Exchange delisting
31 Jul 18
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 18
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 18
Institutional ownership, Q2 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|